The Global Alzheimer’s Platform Foundation Network (GAP-Net) is a non-profit organization created to establish a network of researchers, volunteers & communities curing neurodegenerative disease.
GAP-Net is a patient-centric, non-profit organization dedicated to speeding the delivery of innovative therapies to those living with Alzheimer’s by reducing the time and cost of Alzheimer’s disease (AD) clinical trials. Currently GAP-NET has 90 clinical trial sites across North America. This organization also works with international organizations that share their goals for clinical trial innovation. GAP-NET regularly engages with global partners to coordinate efforts, share information and maintain open dialogue with initiatives under development in a number of countries and continents.
1101 K Street Northwest suite 400, Washington, DC 20005, USA